Concepedia

Richard B. Carter

RB

51

Publications

3.9K

Citations

29

H-Index

1976

Active since

Affiliations

Iowa State University(Current)

University of North Carolina at Chapel Hill

National Institute on Drug Abuse

Purdue Pharma (United States)

Unisys (United States)

Richard B. Carter is an author at Iowa State University specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

1976–2011

51

Publications

51

Underwriter Reputation, Initial Returns, and the Long‐Run Performance of IPO Stocks

Richard B. Carter, Frederick H. Dark, Ajai K. Singh · The Journal of Finance · 1998 · 1.6K citations

, , +14

Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.

Richard B. Carter, Paul L. Wood, Scott Wieland et al. · PubMed · 1997 · 251 citations

, , +16

Underwriter Reputation, Initial Returns, and the Long-Run Performance of IPO Stocks

Richard B. Carter, Rick Dark, Ajai K. Singh · SSRN Electronic Journal · 1998 · 240 citations · Full text

Bootstrap financing and owners’ perceptions of their business constraints and opportunities

Richard B. Carter, Howard Van Auken · Entrepreneurship and Regional Development · 2005 · 136 citations

Anticonvulsant and Behavioral Effects of Neuroactive Steroids Alone and in Conjunction with Diazepam

Maciej Gąsior, Richard B. Carter, Stephen R. Goldberg et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 131 citations

Rows per page

1–5 of 51